Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China.

Breast Cancer Res Treat · 2021 · PMC8558197 · PMID 34471951

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significanceP = 0.15not close (p > 0.1)

Here, we found that the difference in PTEN mutation frequency between the US and CN did not reach statistical significance ( P = 0.15).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.